Crofford L: Prostanoid biology and its therapeutic targeting. Kelley's Textbook of Rheumatology. Edited by: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR. 2013, Philadelphia: Saunders, 871-893. 9
Chapter
Google Scholar
Crofford LJ, Lipsky PE, Brooks P, Abramson SB, Simon LS, van de Putte LBA: Basic biology and clinical application of specific COX-2 inhibitors. Arthritis Rheum. 2000, 43: 4-13. 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V.
Article
CAS
PubMed
Google Scholar
Lanas A: Nonsteridal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer. Am J Med Sci. 2009, 338: 96-106. 10.1097/MAJ.0b013e3181ad8cd3.
Article
PubMed
Google Scholar
Patrono C, Patrignani P, Garcia-Rodrigues LA: Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest. 2002, 108: 7-13.
Article
Google Scholar
Massó González EL, Patrignani P, Tacconelli S, García Rodríguez L: Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010, 62: 1592-1601. 10.1002/art.27412.
Article
PubMed
Google Scholar
Capone ML, Tacconelli S, Rodriguez LG, Patrignani P: NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population. Pharmacol Rep. 2010, 62: 530-535. 10.1016/S1734-1140(10)70310-8.
Article
CAS
PubMed
Google Scholar
Hinz B, Brune K: A ntipyretic analgesics: nonsteroidal anti-inflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb Exp Pharmacol. 2007, 177: 65-93.
Article
CAS
PubMed
Google Scholar
Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem. 2000, 69: 145-182. 10.1146/annurev.biochem.69.1.145.
Article
CAS
PubMed
Google Scholar
Simmons DL, Bottin g RM, Hla T: The biology of prostaglandin synthesis and inhibition. Pharmacol Revs. 2004, 56: 387-437. 10.1124/pr.56.3.3.
Article
CAS
Google Scholar
Llorens O, Perez JJ, Palomar A, Mauleon D: Differential binding mode of diverse cyclooxygenase inhibitors. J Mol Graph Model. 2002, 20: 359-371. 10.1016/S1093-3263(01)00135-8.
Article
CAS
PubMed
Google Scholar
FitzGerald GA, Pa trono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001, 345: 433-442. 10.1056/NEJM200108093450607.
Article
CAS
PubMed
Google Scholar
Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P: Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat. 2007, 82: 85-94. 10.1016/j.prostaglandins.2006.05.019.
Article
CAS
PubMed
Google Scholar
Kurumbail RA, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC: Structural basis for selective inhibition of cyclooxygenase-2 by antiinfl ammatory agents. Nature. 1996, 384: 644-648. 10.1038/384644a0.
Article
CAS
PubMed
Google Scholar
Barkin RL: Topica l nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome. Am J Ther. 2012,
Google Scholar
Kienzler JL, Gold M, Nollevaux F: Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol. 2010, 50: 50-61. 10.1177/0091270009336234.
Article
CAS
PubMed
Google Scholar
Derry S, Moore RA, Rabbie R: Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012, 9: CD007400-
PubMed Central
PubMed
Google Scholar
Lanza PL, Chan FK L, Quigley EMM: Guidelines for prevention of NSAIDrelated ulcer complications. Am J Gastroenterol. 2009, 104: 728-738. 10.1038/ajg.2009.115.
Article
PubMed
Google Scholar
Ashworth NL, Peloso PM, Muhanjarine N, Stang M: Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, arthrotec, diclofenac, and naproxen in a population based cohort study. J Rheumatol. 2005, 32: 2212-2217.
CAS
PubMed
Google Scholar
Gigante A, Tagarro I: Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/ omeprazole. Clin Drug Investig. 2012, 32: 221-233. 10.2165/11596670-000000000-00000.
Article
CAS
PubMed
Google Scholar
Goldstein JL, Hochberg MC, Fort JG, Zhang Y, Hwang C, Sostek M: Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. Aliment Pharmacol Ther. 2010, 32: 401-413. 10.1111/j.1365-2036.2010.04378.x.
Article
CAS
PubMed
Google Scholar
Bello AE: DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug. Ther Adv Musculoskelet Dis. 2012, 4: 327-339. 10.1177/1759720X12444710.
Article
PubMed Central
CAS
PubMed
Google Scholar
Keeble JE, Moore P K: Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal atni-inflammatory and related nitric oxide-donating drugs. Br J Pharmacol. 2002, 137: 295-310. 10.1038/sj.bjp.0704876.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hochberg MC: New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Semin Arthritis Rheum. 2002, 32: 4-14. 10.1053/sarh.2002.37215.
Article
CAS
PubMed
Google Scholar
Ito S, Okuda-Ashit aka E, Minami T: Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res. 2001, 41: 299-332. 10.1016/S0168-0102(01)00289-9.
Article
CAS
PubMed
Google Scholar
Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC: The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostglandin E2 is mediated by inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci. 2001, 21: 5847-5853.
CAS
PubMed
Google Scholar
Kunori S, Matsumura S, Okuda-Ashtaka E, Katano T, Audoly LP, Urade Y, Ito S: A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia. 2011, 59: 208-218. 10.1002/glia.21090.
Article
PubMed
Google Scholar
Ballou LR, Botting RM, Goorha S, Zhang J, R VJ: Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci USA. 2000, 97: 10272-10276. 10.1073/pnas.180319297.
Article
PubMed Central
CAS
PubMed
Google Scholar
Trelle S, Reichenback S, Wandel S, Hildebrand P, Tschannen B, Billiger PM, Egger M, Juni P: Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011, 342: c7086-10.1136/bmj.c7086.
Article
PubMed Central
PubMed
Google Scholar
Brater DC: Anti-inflammatory agents and renal function. Semin Arthritis Rheum. 2002, 32: 33-42. 10.1053/sarh.2002.37216.
Article
CAS
PubMed
Google Scholar
FitzGerald GA: The choreography of cyclooxygenases in the kidney. J Clin Invest. 2002, 110: 33-34. 10.1172/JCI0216044.
Article
PubMed Central
CAS
PubMed
Google Scholar
Harris RC, Breyer MD: Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006, 1: 236-245. 10.2215/CJN.00890805.
Article
CAS
PubMed
Google Scholar
Brater DC, Harris C, Redfern JS, Gertz BJ: Renal effects of COX-2 selective inhibitors. Am J Nephrol. 2001, 21: 1-15. 10.1159/000046212.
Article
CAS
PubMed
Google Scholar
Gurwitz JH, Avorn J, Bonh RL, Glynn RJ, Monane M, Mogun H: Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994, 272: 781-786. 10.1001/jama.1994.03520100043031.
Article
CAS
PubMed
Google Scholar
Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC: Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002, 40: 604-608. 10.1161/01.HYP.0000035856.77718.DA.
Article
CAS
PubMed
Google Scholar
Akhund L, Quinet R J, Ishaq S: Celecoxib-related renal papillary necrosis. Arch Intern Med. 2003, 163: 114-115. 10.1001/archinte.163.1.114.
Article
PubMed
Google Scholar
Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder C-G, Blot WJ, McLaughlin JK, Zack MM, Nyrén O: Acetaminophen, aspirin, and chronic renal failure: a nationwide case-control study in Sweden. N Engl J Med. 2001, 345: 1801-1808. 10.1056/NEJMoa010323.
Article
CAS
PubMed
Google Scholar
Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziono JM: Analgesic use and renal function in men. JAMA. 2001, 286: 315-321. 10.1001/jama.286.3.315.
Article
CAS
PubMed
Google Scholar
Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M: Risk of cardiovascular events and rofecoxib: a cumulative metaanalysis. Lancet. 2004, 364: 2021-2029. 10.1016/S0140-6736(04)17514-4.
Article
CAS
PubMed
Google Scholar
Garcia Rodriguez LA, Tacconelli S, Patrignani P: Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general populations. J Am Coll Cardiol. 2008, 52: 1628-1636. 10.1016/j.jacc.2008.08.041.
Article
PubMed
Google Scholar
FitzGerald GA: Coxibs and cardiov ascular disease. N Engl J Med. 2004, 351: 1709-1711. 10.1056/NEJMp048288.
Article
CAS
PubMed
Google Scholar
Harirforoosh S, Aghazadeh-Habashi A, Jamali F: Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent. Clin Exp Pharmacol Physiol. 2006, 33: 917-924. 10.1111/j.1440-1681.2006.04464.x.
Article
CAS
PubMed
Google Scholar
Mackenzie IS, Coughtrie MW, MacDo nald TM, Wei L: Antiplatelet drug interactions. J Intern Med. 2010, 268: 516-529. 10.1111/j.1365-2796.2010.02299.x.
Article
CAS
PubMed
Google Scholar
Friedewald VE, Bennett JS, Christ o JP, Pool JL, Scheiman Ja, Simon LS, Strand V, White WB, Williams GW, Roberts WC: AJC Editor's Consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010, 106: 873-884. 10.1016/j.amjcard.2010.04.006.
Article
PubMed
Google Scholar
Solomon SD, Wittes J, Finn PV, Fo wler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, Pater JL, Goss PE, Lance P, Obara S, Chew EY, Kim J, Arndt G, Hawk E, Cross Trial Safety Assessment Group: Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial sarety analysis. Circulation. 2008, 117: 2104-2113. 10.1161/CIRCULATIONAHA.108.764530.
Article
PubMed Central
CAS
PubMed
Google Scholar
Feenstra J, Heerdink ER, Grobbee DE, Stricker BR: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with replapsing heart failure: the Rotterdam Study. Arch Intern Med. 2002, 162: 265-270. 10.1001/archinte.162.3.265.
Article
CAS
PubMed
Google Scholar
Page J, Henry D: Consumption of N SAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med. 2000, 160: 777-784. 10.1001/archinte.160.6.777.
Article
CAS
PubMed
Google Scholar
Brater DC: Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs. Am J Med. 1986, 80: 62-
Article
CAS
PubMed
Google Scholar
Colebatch AN, Marks JL, van der Heijde DM, Edwards CJ: Safety of nonsteroidal anti-inflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012, 90: 62-73. 10.3899/jrheum.120345.
Article
CAS
PubMed
Google Scholar
White WB: Defining the problem of treating the patient with hypertension and arthritis pain. Am J Med. 2009, 122 (5 Suppl): S3-S9.
Article
PubMed
Google Scholar
Mort JR, Aparasu RR, Baer RK: Interaction between selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs: review of the literature. Pharmacotherapy. 2006, 26: 1307-1313. 10.1592/phco.26.9.1307.
Article
CAS
PubMed
Google Scholar
Hauber AB, Arden NK, Mohamed AF, Johnson FR, Peloso PM, Watson DJ, Mavros P, Gammaitoni A, Sen SS, Taylor SD: A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis. Osteoarthritis Cartilage. 2013, 21: 289-297. 10.1016/j.joca.2012.11.007.
Article
CAS
PubMed
Google Scholar
Wolfe F, Zhao S, Lane N: Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum. 2000, 43: 378-385. 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2.
Article
CAS
PubMed
Google Scholar
Pincus T, Koch GG, Sokka T, Lefko with J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnitzer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J: A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum. 2001, 44: 1587-1598. 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X.
Article
CAS
PubMed
Google Scholar
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P: OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010, 18: 476-499. 10.1016/j.joca.2010.01.013.
Article
CAS
PubMed
Google Scholar